首页>Anti-cancer agents in medicinal chemistry>A small-molecule inhibitor, 5′-o-Tritylthymidine, targets FAK and Mdm-2 interaction, and blocks breast and colon tumorigenesis in vivo
A small-molecule inhibitor, 5′-o-Tritylthymidine, targets FAK and Mdm-2 interaction, and blocks breast and colon tumorigenesis in vivo
作者单位:UF Shands Cancer Center, Gainesville, FL, United States[1]Department of Surgical Oncology, Roswell Park Cancer Research Institute, Buffalo, NY 14263, United[2]Department of Pathology, UF Shands Cancer center, Gainesville, FL, United States[3]